Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates
How did your country report this? Share your view in the comments.
Diverging Reports Breakdown
Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates
Big follow-on public offerings in late June and early July. $402.5m for Cidara, $250.8m for Kymera and $230m for Dyne. Revolution Medicines accessed up to $
Read full article ▼
Public Company Edition: A breakthrough designation, data and deals prompted big follow-on public offerings in late June and early July, including $402.5m for Cidara, $250.8m for Kymera and $230m for Dyne. Also, Revolution Medicines accessed up to $2bn from Royalty Pharma.
Source: Insights.citeline.com | View original article